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Introduction
Puberty and the timing of  puberty onset are dependent on an intact network of  gonadotropin-releasing 
hormone (GnRH) neurons working together with their afferent and efferent neural and glial connections. 
Development of  this GnRH neuroendocrine network requires a coordinated and timely migration of  neu-
rons from the vomeronasal organ (VNO) in the nose to the hypothalamus during embryonic life. We have 
previously demonstrated that dysregulation in the migratory process leads not only to GnRH deficiency but 
also to self-limited delayed puberty (DP) (1, 2).
A multitude of  factors, important for GnRH neuronal migration and differentiation and hypothalamic 
and pituitary development, are required for the correct organization of  this system. As part of  the search 
for understanding these key influences, large GWASs of  age at menarche have identified signals in or near 
several candidate genes with relevance to forebrain development and function, including POU1F1, TENM2, 
and FRS3 and signals representing cis-expression quantitative trait loci for leucine-rich repeat–containing G 
The initiation of puberty is driven by an upsurge in hypothalamic gonadotropin-releasing hormone 
(GnRH) secretion. In turn, GnRH secretion upsurge depends on the development of a complex 
GnRH neuroendocrine network during embryonic life. Although delayed puberty (DP) affects up 
to 2% of the population, is highly heritable, and is associated with adverse health outcomes, the 
genes underlying DP remain largely unknown. We aimed to discover regulators by whole-exome 
sequencing of 160 individuals of 67 multigenerational families in our large, accurately phenotyped 
DP cohort. LGR4 was the only gene remaining after analysis that was significantly enriched for 
potentially pathogenic, rare variants in 6 probands. Expression analysis identified specific Lgr4 
expression at the site of GnRH neuron development. LGR4 mutant proteins showed impaired 
Wnt/β-catenin signaling, owing to defective protein expression, trafficking, and degradation. Mice 
deficient in Lgr4 had significantly delayed onset of puberty and fewer GnRH neurons compared with 
WT, whereas lgr4 knockdown in zebrafish embryos prevented formation and migration of GnRH 
neurons. Further, genetic lineage tracing showed strong Lgr4-mediated Wnt/β-catenin signaling 
pathway activation during GnRH neuron development. In conclusion, our results show that LGR4 
deficiency impairs Wnt/β-catenin signaling with observed defects in GnRH neuron development, 
resulting in a DP phenotype.
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protein–coupled receptor 4 (LGR4) (3). LGR4 was also identified as a candidate gene for the genetic regula-
tion of  pubertal timing in an additional GWAS, which found 1 rare nonsense variant to be associated with 
the late onset of  menarche, low levels of  testosterone, and low bone mineral density (4). LGR4 encodes a 
receptor for R-spondins, the activation of  which potentiates the canonical Wnt signaling pathway. Addi-
tionally, it is involved in the development of  various organs, including the eyes, liver, reproductive tract, and 
bone (5). Notably, LGR4 mutations have not been shown previously to be causal in human disease.
DP affects up to 2% of the population and is associated with adverse health outcomes (6, 7). Self-limited 
DP (also known as constitutional delay of puberty) is defined as the absence of testicular enlargement in boys 
or breast development in girls at an age that is 2–2.5 SD later than the population mean (8). Self-limited DP is 
often familial and is highly heritable, most commonly seen with an autosomal dominant inheritance pattern, 
indicating the importance of genetic regulation in this phenotype (9). However, for most patients with DP the 
pathogenic mechanism and genetic basis of their condition remains unknown. We aimed to investigate if  defects 
in further pathways regulating GnRH neuronal migration and development could lead to DP onset in our large, 
accurately phenotyped cohort of patients with DP. Using a combination of genetic, in silico, in vitro, and in vivo 
approaches, we have identified that defects in Lgr4 disrupt Wnt/β-catenin signaling appear to affect the develop-
ment of the GnRH neuronal network, and lead to a phenotype of disrupted pubertal onset in mice and humans.
Results
Exome sequencing of  families with self-limited DP identifies potentially pathogenic variants in LGR4. Whole and 
targeted exome sequencing of  67 informative families from our large cohort with self-limited DP identified 
8 genes significantly enriched with rare, potentially pathogenic variants by whole gene burden testing of  
rare variants. These candidates included 4 genes demonstrated previously to be relevant to the pathogen-
esis of  DP (IGSF10, HS6ST1, EAP1, and FTO; refs. 1, 2, 10, and 11), 3 genes that were excluded after 
Sanger sequencing in patients and controls (LRRIQ3, SEC24A, and ZNF560), and the candidate gene LGR4 
( ENSG00000205213, gene identification number 107515) (Figure 1A).
Pedigrees with a potentially pathogenic LGR4 variant display an autosomal dominant inheritance pattern 
and classical self-limited DP. We identified 3 rare missense variants in LGR4 (NM_018490.3: c.286A>G 
(rs757351670) p.Ile96Val; NM_018490.3: c.1087G>T (rs117543292) p.Gly363Cys; and NM_018490.3: 
c.2531A>G (rs34804482) p.Asp844Gly) in 6 unrelated families (17 affected individuals) from our familial 
DP cohort. All segregated with the DP trait with the expected autosomal dominant pattern of  inheritance 
(Figure 1B). All 6 probands were male; however, 2 families contained affected females with maternal inher-
itance demonstrated in both families. All probands had delayed onset of  Tanner stage G2 with low serum 
gonadotropins and serum testosterone (Table 1). Four of  the six males had a height standard deviation 
score of  >–2.0, with a markedly delayed bone age at presentation, and a concurrent delay in age of  peak 
height velocity was recorded for 4 of  the 6 probands. All of  the males had spontaneously attained Tanner 
stage G4 or more by 18 years of  age, excluding hypogonadotropic hypogonadism. None of  the affected 
individuals had other syndromic features, developmental eye conditions, or other known neurological fea-
tures. However, MRI brain imaging was not undertaken in any of  these individuals.
In silico analysis of  LGR4 variants highlights their likely pathogenicity. LGR4 is a large protein consisting 
of  17 extracellular leucine-rich repeats (LRRs) together with a 7-transmembrane region (4). Two variants 
identified are located in the extracellular (p.I96V and p.G363C) domain, and one variant is located in the 
intracellular (p.D844G) domain (Supplemental Figure 1A; supplemental material available online with this 
article; https://doi.org/10.1172/jci.insight.133434DS1). All 3 variants affect amino acids that are highly 
conserved, as revealed by genomic evolutionary rate profiling score and multiple sequence alignment (Sup-
plemental Figure 1B). Two variants (p.Gly363Cys and p.Asp844Gly) are predicted to be deleterious by 
≥three-fifths of  the main prediction software tools (Supplemental Figure 1C).
In silico analysis of  the glycine-to-cysteine change at position 363 (Protein Data Bank: 4KT1, 2.5 Å) 
revealed that it occurs in the variable region of  LRR 12 of  the extracellular domain, and that this substitu-
tion introduces a steric clash. Moreover, glycine 363 is juxtaposed with cysteine 364, which forms a cyste-
ine bond with cysteine C339. Overall, this amino acid substitution may alter the structural stability of  the 
LGR4 extracellular domain, thus compromising its protein-binding ability.
The aspartic acid-to-glycine substitution at position 844 lies within the cytoplasmic domain and intro-
duces a small neutral residue in place of  the large, negatively charged aspartic acid. Overall, this substitu-
tion is predicted to have a damaging effect on LGR4 structure and/or function.
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The third variant (p.Ile96Val) lies in the variable region of  LRR 2 in the extracellular domain. This variant 
was retained for functional annotation, despite not being predicted by in silico analysis to cause a major struc-
tural change to the LGR4 protein, in view of  its rarity and perfect segregation in a large pedigree (Figure 1C).
Lgr4 is expressed in key areas responsible for GnRH neuronal development and acts through Wnt/β-catenin sig-
naling. Lgr4 mRNA is strongly expressed in the adult mouse in cartilage and bone, kidney, adrenal gland, 
and testis, and at a lower intensity in many other organs. In the mouse embryo, Lgr4 expression is seen 
in the VNO and olfactory epithelium (OE) as well as in the eyes, ribs, and esophagus (12). Using in situ 
hybridization we detected marked expression of  Lgr4 mRNA in the VNO, OE, and at the level of  the ven-
tral hypothalamus of  the developing mouse embryo (Figure 2, A–H, and ref. 12), suggesting a potential 
Figure 1. Identification of LGR4 as a candidate gene for self-limited DP with rare pathogenic variants in patients. (A) Whole-exome sequencing (WES) 
was performed on 160 individuals from our cohort (125 with self-limited DP and 35 controls). Variants were filtered using filters for quality control, pre-
dicted functional annotation, minor allele frequency (MAF), and for genes with variants in multiple families. A total of 28 genes were prioritized and were 
targeted exome sequenced in additional 288 individuals. Further analysis identified genes significantly enriched for pathogenic variants via whole gene 
burden testing, and genes involved in GnRH neuronal development and puberty timing (1, 2, 10, 11). Excluded, owing to the presence of variants in multiple 
controls. (B) Squares and circles indicate male and female family members, respectively. Black symbols represent affected individuals, gray symbols repre-
sent unknown phenotype, and clear symbols represent unaffected individuals. “P” indicates the proband in each family, and “us” indicates unsequenced 
owing to lack of DNA. A black line above an individual’s symbol indicates heterozygosity for that mutation as confirmed by either WES or Fluidigm 
array, and verified by Sanger sequencing. (C) LGR4 extracellular domain (gold) with variants bound to R-spondin1 (blue). Variants p.I96V and p.G363C are 
presented (green). p.I96V and p.G363C are in the variable region of LRR2 and LRR12, respectively. p.G363C occurs in close proximity to a cysteine bond 
(C339-C364; orange), and this substitution introduces a steric clash. p.D844G is within the cytoplasmic domain, and no experimental structure for the 
LGR4 cytoplasmic domain was available. DP, delayed puberty.
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role in the development or migration of  GnRH neurons. Lgr4 mRNA was detected early in development, at 
E10.5 in the anlage of  the OE (Figure 2, A and B). GnRH neurons were seen adjacent to the VNO at E14.5 
(Figure 2, C and D) in a strongly Lgr4-positive milieu, and also migrating alongside Lgr4-positive ventral 
hypothalamic cells (Figure 2, G and H).
At E12.5, GnRH neurons that had exited the VNO into the nasal mesenchyme were found not to express 
Lgr4, using combined immunofluorescence and in situ hybridization, although some potential co-expression 
within the VNO in GnRH progenitor cells or early neurons cannot be excluded (Supplemental Figure 2, A–I).
Lgr4 is known to act via Wnt/β-catenin signaling (5, 13); therefore, to examine the activity of  
this pathway during GnRH neuronal development and migration we used an Axin2creERT2/+ RosaYFP/
YFP mouse model, which is a reporter line known to reliably act as a readout for Wnt-responsive cells 
(14). We administered tamoxifen to pregnant females at E12.5 and examined embryos at E19.5, when 
GnRH neurons have reached the hypothalamus (Figure 2I). We found a strong signal in the VNO and 
OE, exactly matching the expression pattern of  Lgr4 (negative control: Figure 2, J–M). Interestingly, 
all GnRH neurons migrating to, or within, the hypothalamus were found to be GFP negative (Figure 
2, N–Q), whereas the hippocampus (HC, Figure 2, N and O) was strongly GFP positive, as previously 
reported (14). These data demonstrate that Lgr4 is strongly expressed in the VNO, a key region respon-
sible for GnRH neuronal differentiation and a hub for Wnt/β-catenin activity, and that nascent GnRH 
neurons located in the VNO might be affected by responsive Wnt/β-catenin signaling. Taken together, 
this points to a potential role of  Lgr4 in GnRH neuronal development, or in their exit from the VNO 
to begin migration.
LGR4 mutant receptors impair Wnt/β-catenin signaling. To measure the function of  LGR4 variants through 
Wnt/β-catenin signaling, we used a TOP-Flash luciferase reporter assay. HEK293T cells were transiently 
transfected with reporter and WT or mutated LGR4 constructs (p.Ile96Val = I96V; p.Gly363Cys = G363C; 
p.Asp844Gly = D844G). Upon activation of  the pathway with conditioned media (Wnt3a and Rspol), all 
3 LGR4 mutants had a significantly reduced ability to activate canonical Wnt/β-catenin signaling as com-
pared with LGR4 WT normalized luciferase activity (180.6 ± 16.4) versus I96V (140.2 ± 3.9, P < 0.0001), 
versus G363C (148.3 ± 4.7, P = 0.0004), versus D844G (160.8 ± 13.5, P = 0.043) (Figure 3A).
Table 1. Clinical data of the 6 probands carrying rare pathogenic variants in LGR4, both at presentation and at the end of follow up
p.I96V family A p.G363C family B p.G363C family C p.G363C family D p.G363C family E p.D844G family F
At presentation
Age (yrs) 12.5 12.0 15.6 13.8 14.8 15.3
Bone age (yrs) 11.0 7.5 13.0 12.0 11.0 11.5
Height SDS –0.6 –2.9 –2.6 –1.3 –2.1 –2.5
G stage 1 1 1 1 1 1
P stage 1 1 1 1 1 1
Testicular volume (mL) 2 2 3 2 2 3
S-LH (1U/L) 0.2 0.4 0.9 0.5 0.6 0.6
S-FSH (1U/L) 0.8 n/a 1.2 0.9 1.0 0.8
S-testosterone (nmol/L) 0.4 0.2 1.1 0.5 0.5 0.4
At the end of follow-up
Age (yrs) 16.2 19.5 18.1 19.2 18.9 17.0
Height SDS 0.5 –2.8 n/a –0.7 n/a –1.8
G stage 5 5 5 n/a 5 4
P stage 4 5 4 n/a 5 4
Testicular volume (mL) 15 20 20 25 20 12
S-LH (1U/L) 2.1 n/a 3.6 4.1 n/a
S-FSH (1U/L) 3.1 n/a 5.1 4.6 n/a
S-testosterone (nmol/L) 15.1 24.1 17.5 22.3 24.0 16.2
Age at take off (yr) 14.5 14.0 n/a 14.5 n/a 15.8
Age of PHV (yr) 15.3 15.0 n/a 15.3 n/a 16.1
G stage, Tanner gonadal stage; P stage, Tanner pubic hair stage; S-LH, serum luteinizing hormone; S-FSH, serum follicle stimulating hormone; PHV, peak 
height velocity; SDS, standard deviation score.
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With the aim of  clarifying the molecular mechanisms underlying this impaired signaling activity, we 
first analyzed the expression levels of  LGR4 WT and mutated proteins. Western blot analysis of  HA-tagged 
human LGR4 (HA-hLGR4) proteins revealed multiple specific bands at different molecular weights: 1 
band at approximately 100 KDa, matching the expected molecular weight of  LGR4 protein (104 KDa), 
and multiple additional bands at higher molecular weights, as previously reported (15). HA-hLGR4 mutat-
ed protein normalized levels were significantly reduced (Figure 3B, densitometric analysis), suggesting 
defective protein production caused by all 3 LGR4 mutations. In comparison to WT (100%), mutant LGR4 
protein levels were reduced to 33.7% ± 4.2% (P = 0.0011), 33.7% ± 11.7% (P = 0.0011), and 36.0% ± 10.0% 
Figure 2. Lgr4/Wnt/β-catenin complex is expressed in key regions for GnRH neuronal development and migration. 
(A and B) Low- and high-magnification images of in situ hybridization analysis revealing Lgr4 mRNA localization in 
the OE at E10.5. (C and D) At E14.5, the signal is strongly visible in the VNO and immunohistochemistry reveals GnRH 
neurons exiting the VNO. (E and F) Low- and high-magnification images showing Lgr4 mRNA preferentially localized in 
the VNO, OE, and nuclei of the forebrain at E14.5. (G and H) Low- and high- magnification images showing Lgr4 expres-
sion at E17.5 in the OE and in an area of the HYP where GnRH neurons (brown) are migrating alongside. (I) Schematic 
showing the mouse model employed for lineage tracing. (J and K) Axin2+/+ RosaYFP/YFP control mice reveal a faint and not 
specific staining for Axin2-GFP. (L and M) In Axin2CreERT2/+ RosaYFP/YFP embryos, Axin2-GFP-positive cells are expressed 
in the VNO and OE, indicating the presence of Wnt/β-catenin responsive cells. (N and O) Low- and high-magnification 
images of same specimen showing GFP-positive cells located exclusively in the HC, whereas the MPA is negative. (P) 
Immunohistochemical detection of GnRH neurons followed by (Q) immunofluorescence for GFP in Axin2CreERT2/+ RosaYFP/
YFP embryos. A representative GnRH neuron is GFP negative. Scale bars: 25 μm (A–H), 100 μm (J–M), 250 μm (N), 50 μm 
(O–Q). Representative images of experiments were performed at least 3 independent times. Arrowheads point to GnRH 
neurons. 3V, third ventricle; E, embryonic day; HC, hippocampus; HYP, hypothalamus; MPA, medial preoptic area; MV, 
mesencephalic vesicle; OE, olfactory epithelium; Pir, piriform cortex; TV, telencephalic vesicle; VNO, vomeronasal organ. 
(A and B) Sagittal sections; (C–Q) coronal sections.
6insight.jci.org   https://doi.org/10.1172/jci.insight.133434
R E S E A R C H  A R T I C L E
(P = 0.0014) for the I96V, G363G, and D844G variants, respectively. These data were corroborated by flow 
cytometry analysis of  plasma membrane expression of  LGR4 proteins (Figure 3C). In comparison to WT 
(100%), the normalized median fluorescent intensity (nMFI) of  mutated proteins was reduced to 64.9% ± 
6.2% (P = 0.0049), 51.3% ± 19.2% (P = 0.0647), and 59.0% ± 9.3% (P = 0.0117) for the I96V, G363C, and 
D844G variants, respectively.
We also compared the half-life of  WT and mutant LGR4 proteins in HEK293T cells by treating trans-
fected cells with cycloheximide (CHX) at different time points (0, 3, 6, 9, and 12 hours). Although the 
intracellular variant (D844G) had a half-life (12.89 hours) similar to the WT (15.3 hours), the 2 extracel-
lular variants (I96V and G363C) had a significantly shortened half-life (6.7 and 5.9 hours, respectively) 
compared with the WT protein (Figure 3D), as also confirmed by the difference in degradation speed (K) 
of  the WT protein and that of  the 2 mutant proteins, I96V (P = 0.0008) and G363C (P = 0.0042). Together, 
these data demonstrate that these LGR4 mutations result in lower protein expression levels as a whole and 
in the plasma membrane, and that 2 mutants also had a faster protein turnover. These factors are likely to 
both contribute to the lower activation of  Wnt/β-catenin observed.
Lgr4+/– mice have a significantly delayed onset of  puberty and reduced number of  GnRH neurons. To test the 
hypothesis that heterozygous Lgr4 deficiency is sufficient to cause DP in vivo, we compared the timing of  
puberty in Lgr4+/– and Lgr4+/+ female mice by identifying the day of  vaginal opening (VO), a proxy mea-
surement for pubertal onset in mice (16). We found that VO was delayed on average by 2.06 ± 1.3 days (P 
= 0.0097) in Lgr4 +/– compared with Lgr4+/+ females (Figure 4A); at the time of  VO, the Lgr4+/– and Lgr4+/+ 
female mice had similar body weights (Figure 4B). Despite DP, the fertility of  young adult Lgr4+/– mice of  
both sexes appeared normal, because they seared litters without obvious delay and litters were of  similar 
size to WT mice at 4–6 months of  age (Figure 4C). In agreement with the ability to mother litters of  normal 
size, gonadal size was similar in young adult Lgr4+/– and Lgr4+/+ female mice (Figure 4, D–J). Taken togeth-
er, these findings suggest — consistent with the human phenotype — that Lgr4 haploinsufficiency delays 
puberty without compromising fertility in the adult. In contrast, Lgr4–/– mice failed to enter puberty entirely 
and demonstrated substantially reduced gonadal size (Figure 4, A and D–J).
In view of  the evidence that Lgr4 may affect GnRH development or migration, we next assessed the 
number of  GnRH neurons in the nasal placode region during early embryogenesis, and in the hypothala-
mus in later embryogenesis and in postnatal mice. The number of  GnRH neurons was markedly decreased 
in the Lgr4 –/– mice as compared with WT. At E12.5, E16.5, and adult age, Lgr4 –/– mice presented a reduc-
tion of  GnRH neurons of  68.5% ± 28%, 52.0% ± 25.9%, and 50.7% ± 32.6%, respectively, as compared 
with Lgr4+/+ (Figure 4, K–M). An intermediate phenotype in GnRH number was observed in the heterozy-
gous Lgr4+/– mice at all 3 developmental stages. GnRH neuron morphology appeared unchanged in the het-
erozygous and homozygous mice as compared with WT (Supplemental Figure 3, A–I). Weight and gross 
anatomy of  the brain were not significantly different between the 3 groups (Supplemental Figure 4, A–D).
Knockdown of  lgr4 in zebrafish embryos impairs gnrh3 neuronal development. To further characterize the role 
of  LGR4 during GnRH neuron development, we investigated knockdown (KD) of  lgr4 in a well-established 
transgenic gnrh3:gfp zebrafish model (17, 18), first using splice site-blocking morpholino (MO) for transient 
KD (Figure 5A). MO doses (1 pmol/embryo and 1.25 pmol/embryo) were selected because they reduced 
expression to 50% and < 10% of  WT lgr4 mRNA, thus producing conditions similar to the heterozygous 
and homozygous state (Supplemental Figure 5, A–C).
At 48 hpf, embryos injected with 1 pmol/embryo displayed a significant reduction in MFI of  GnRH3 
fibers at the level of  the anterior commissure (AC), optic chiasm (OC), and retina (Re) (Figure 5, C and H; 
MFI: 11310 ± 590.6) in comparison with controls (Figure 5, B and H; MFI: 13132 ± 482.2; P = 0.027). 
Injection of  1.25 pmol/embryo led to a more severe reduction in the formation of  GnRH3 fibers (Figure 5, D 
and H; MFI: 4475 ± 408.3; P = 1 × 10–5). Similarly, at 72 hpf, migration of  GnRH3 axon fibers to the hypo-
thalamus was affected in embryos injected with 1 pmol/embryo lgr4MO (Figure 5, F and I; MFI: 23,250 ± 
1285.8) when compared with controls (Figure 5, E and I; MFI: 26,863 ± 1046.5; P = 0.03), and more severely 
disrupted in 1.25 pmol/embryo injected morphants (Figure 5, G and I; MFI: 6366 ± 389.2; P = 5 × 10–7).
To confirm the effects on GnRH3 system development of  lgr4 inactivation, we used a CRISPR/Cas9 
phenotyping protocol that relies on repeated noninvasive live analysis of  GnRH3 neuron development in 
control and Crispant tg(gnrh3:gfp) fish. The single-guide RNA (sgRNA) was designed to cause a deletion 
of  a region of  about 500 bp containing the transcription start site of  the lgr4 mRNA (Figure 5J and Sup-
plemental Figure 5, D–F). Crispant-Wt displayed normal development of  GnRH3 neurons as compared 
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Figure 3. LGR4 mutant receptors affect Wnt/β-catenin signaling owing to defects in protein production, trafficking, and protein turnover. (A) 
HEK293T were nontransfected (–) or transfected (+) with HA-hLGR4 plasmids (WT or mutants; 200 ng/well) and reporter vectors (TOP-Flash and 
Renilla [150 ng/well]). Signaling was activated with conditioned media treatment, and each transfection normalized by cotransfection with Renilla. 
HA-hLGR4 mutant receptors resulted in significant reduced luciferase activity. ****P < 0.0001, ***P = 0.004, *P = 0.0437; n = 4. (B) Western blot and 
densitometry analysis revealed reduced levels of LGR4 mutants. GAPDH was used as loading control. Molecular weight (KDa) of a protein standard is 
reported (left panel: WT vs. I96V **P = 0.0054; WT vs. G363C **P = 0.0039; WT vs. D844G **P = 0.0049); n = 3. (C) Representative plots and quantifi-
cation of flow cytometry analysis of cell surface expression of WT and mutant LGR4 proteins expressed in HEK293T. Normalized median fluorescence 
intensity (nMFI) reveals reduced levels of mutant receptors at the plasma membrane compared with HA-hLGR4 WT (WT vs. p.G363C *P = 0.0228; WT 
vs. p.D844G *P = 0.0498). Control: HEK293T transfected with pcDNA3.1EGFP vector only. n = 3. (D) LGR4 mutants have a shorter half-life: transiently 
transfected HEK293T with HA-hLGR4 WT or mutant constructs treated with CHX (50 μg/mL) for different time periods (0, 3, 6, 9, and 12). Levels of 
LGR4 WT and mutant proteins were expressed relative to untreated LGR4 WT or mutant proteins (0 h); n = 4. Statistical analysis by 1-way ANOVA. 
Half-life was analyzed via a 1-phase decay equation, and degradation speed (K) compared between each mutant and WT protein using the extra sum-
of-squares F test. Co, control medium; Rspo1, Rspondin-1.
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with uninjected embryos at 48 and 72 hpf  (Figure 5, K, L, O, and P), as revealed by MFI at 48 hpf  (Figure 
5S) and at 72 hpf  (Figure 5T). Similar to the MO results, at 48 hpf  homozygous Crispants (Crispant-Hom) 
displayed a disorganization of  the olfactory bulbs (OBs) with a significant reduction of  MFI of  GnRH3 
fibers at the level of  AC, OC, and Re (Figure 5, N and S; MFI: 6052 ± 399.9), as compared with uninjected 
embryos (Figure 5, K and S; MFI: 15,669 ± 777.9; P = 8 × 10–6). At 48 hpf, heterozygous Crispants (Cris-
pant-Het) showed a milder, but significant, reduction in GnRH3 neuronal development compared with 
uninjected embryos (Figure 5, M and S; MFI: 11,297 ± 1035.1; P = 0.0003), whereas at 72 hpf  no signifi-
Figure 4. Lgr4–/– female mice fail to enter puberty and show reduced number of GnRH neurons during fetal and adult life. (A) Vaginal opening for pubertal 
onset shows that Lgr4+/– mice have a significant (*P = 0.01) delayed onset of puberty compared with Lgr4+/+. Lgr4–/– female mice fail to enter puberty com-
pletely. Lgr4+/+ n = 10, Lgr4+/– n = 23, Lgr4–/– n = 7. (B) Lgr4+/– mice are not smaller than Lgr4+/+, as shown by the percentage relative to Lgr4+/+. Lgr4+/+, n = 10; 
Lgr4+/–, n = 15. (C) Litter size is not affected when pairing Lgr4+/+ with Lgr4+/–. Crosses between Lgr4+/+ × Lgr4+/+ and Lgr4+/+ × Lgr4+/– harbor a normal number 
in litter size, proving that fertility is not affected in Lgr4+/– males and females. Lgr4+/+, n = 10; Lgr4+/–, n = 23. (D–F) Show gross anatomy of Lgr4+/+, Lgr4+/–, and 
Lgr4–/– reproductive tracts, respectively. (G–I) Show gross anatomy of Lgr4+/+, Lgr4+/–, and Lgr4–/– ovaries, respectively. (J) Lgr4–/– females show reproductive 
tracts significantly reduced in weight compared with Lgr4+/+ females (*P = 0.0366); n = 3. Scale bars: 2.5 mm (D–F), 1 mm (G–I). (K–M) GnRH neurons number 
in E12.5, E16.5, and adults, respectively. In K, Lgr4+/+ = 3, Lgr4+/– = 3, Lgr4–/– = 2; in L, Lgr4+/+ = 2, Lgr4+/– = 4, Lgr4–/– = 3; in M, Lgr4+/+ = 5, Lgr4+/– = 3, Lgr4–/– = 3. In 
all groups, Lgr4–/– mice show a reduced number of GnRH neurons compared with Lgr4+/+. (Adults, *P = 0.0265). Lgr4+/– mice show a similar trend although not 
statistically significant. Unpaired 2-tailed t test was used for statistical analysis for (A–C) and (J). Kruskal-Wallis test was used for M.
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cant changes were observed (Figure 5, Q and T). At 72 hpf, the GnRH3 signal in the AC as well as in the 
hypothalamic innervations was strongly reduced in Crispant-Hom as compared with uninjected embryos 
(Figure 5, R and T; uninjected MFI: 29,059 ± 828.7 vs. Crispant-Hom MFI: 9766 ± 261.6; P = 2 × 10–7). 
Taken together with the previous results from our study, these data demonstrate that lgr4 is required for 
regulation of  the development of  the GnRH neuronal system in mouse, zebrafish, and humans.
Figure 5. Lgr4 impairs GnRH3-neuron development in morphants and Crispants Zebrafish. (A) Morpholino-mediated (MO-mediated) knockdown of the 
lgr4 gene in zebrafish: representation of lgr4 pre-mRNA. The lgr4MO targeted the exon2-intron2 boundary (red line). (B–G) Live-imaging acquisition of 
GnRH3 neurons in lgr4 morphants. (B and E) normal development of GnRH3 neurons at 48 and 72 hpf. Strong GnRH3 signal is visible at the level of the 
OBs, AC, along the OC and Re. At 72 hpf, GnRH3 hypothalamic (Hy) projections (asterisks) are also detectable. (C and F) embryos injected with 1 pmol/
embryo. (D and G) embryos injected with 1.25 pmol/embryo. Images are acquired in ventral view, anterior to the top. (H and I) Quantification of the mean 
fluorescence intensity (MFI) using ImageJ Software. A significant reduction in MFI was observed in morphants vs. ctrl: at 48 hpf, lgr4MO 1 pmol/embryo *P 
= 0.0268; lgr4MO 1.25 pmol/embryo ****P < 0.0001; at 72 hpf, lgr4MO 1.25 pmol/embryo *P = 0.0290; lgr4MO 1.25 pmol/embryo ****P < 0.0001; n = 15 (J) 
Crispr/Cas-mediated KO of the lgr4 gene in zebrafish: representation of lgr4 gene, including the ATG start site and regulatory regions located in the 5′ UTR 
(black triangles). Localization of the 2 sgRNAs used (red lines). (K–R) Live-imaging acquisition of GnRH3 neurons in lgr4 Crispants. (K and O) uninject-
ed embryos. (L and P) Crispant-Wt. (M and Q) Crispant-Het. (N and R) Crispant-Hom (all at 48 and 72 hpf). (S and T) A significant reduction in MFI was 
observed in Crispants vs. ctrl. At 48 hpf, Crispant-Het ***P = 0.0003; Crispant-Hom ****P < 0.0001; at 72 hpf Crispant-Hom ****P < 0.0001; n = 15. Red 
squares indicate region of interest (ROI) used for GnRH3 fiber quantification. Scale bars: 50 μm (B–G and K–R). Statistical analysis by 1-way ANOVA.
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Discussion
DP can be a clinical presentation of  many different pathological mechanisms. Recent evidence has demon-
strated that there may be a fetal origin of  disorders of  pubertal timing, with deficiency in key genes that 
govern the development of  the gonadotropin releasing hormone system resulting in a spectrum of  condi-
tions ranging from isolated DP to absent puberty with anosmia (19–21). However, the genetic basis of  DP 
remains largely unclear. We aimed to further explore the hypothesis that defects of  GnRH neuronal devel-
opment could present with a DP phenotype in adolescence, with subsequent normal reproductive capacity.
In this study, we have identified 3 deleterious mutations in LGR4 in 6 unrelated pedigrees with self-limited 
DP, and describe the mechanistic basis for their pathogenicity and influence on the timing of  pubertal onset. 
Lgr4 is known to modulate the Wnt/β-catenin signaling cascade and to be important for development and 
stem cell survival (22). It is thought to act, once coupled to its ligand R-spondin, to prevent Wnt receptor 
degradation via inhibition of  ubiquination by Rnf43 and Znrf3 (23). LGR4 had already been implicated as a 
regulator of  pubertal timing through GWAS of age at menarche in women and age of  voice break in men (4, 
7); however, mutations in LGR4 had not previously been demonstrated to be causal in human disease.
Rare pathogenic variants in LGR4 were enriched in our self-limited DP cohort as compared with con-
trol populations, and these mutations were inherited in the recognized autosomal dominant pattern seen 
in this condition (9, 24). The affected members of  these families displayed typical self-limited DP, with 
puberty onset having commenced before 18 years of  age. None of  the affected individuals had neurologi-
cal or other associated phenotypic abnormalities (25). The variants identified all led to functional impair-
ment of  LGR4 protein ability to activate Wnt signaling, as demonstrated by luciferase reporter assay. All 
3 resulted in decreased protein expression, owing to reduced cell surface expression, faster degradation, or 
both, pointing to a reduced protein bioavailability accounting for the DP phenotype (26). Interestingly, the 
3 mutations are found in different domains in the LGR4 protein, 2 within LRR regions of  the extracellu-
lar domain, and 1 within the cytoplasmic domain. Complementing previous studies, we have shown that 
LGR4 is highly expressed in the VO, OE, and hypothalamus of  the developing mouse (12).
To investigate the role LGR4 plays in pubertal timing in vivo, we used 2 different murine models. 
First, lineage-tracing analysis identified activation of  the Wnt/β-catenin pathway in embryonic regions 
with strong Lgr4 expression, including the VNO and OE. The observation that hypothalamic GnRH neu-
rons were descendant of  cells not endowed with endogenous Wnt/β-catenin activity suggests the intriguing 
possibility that nascent and/or migrating GnRH neurons might be affected by Lgr4 signaling by adjacent 
cells in a paracrine fashion. Second, using a Lgr4 KO mouse model we were able to determine that Lgr4 
deficiency results in reduced numbers of  GnRH neurons at both early migratory stages and within the 
hypothalamus. Corroborating data from confocal evaluation of  transgenic gnrh3:gfp zebrafish also point to 
the relevance of  lgr4 during the early development of  GnRH3 neurons.
Previous data show that a functional redundancy exists within the GnRH neuronal population (27), 
thus LGR4 deficiency, via defective Wnt/β-catenin signaling, may not only reduce GnRH neuronal number 
but also affect the function of  these neurons within the hypothalamic neurosecretory network. This hypoth-
esis requires future investigation beyond the scope of  this manuscript.
The DP phenotype seen in our patients with heterozygous LGR4 mutations was recapitulated in the 
Lgr4+/– mice, which demonstrated late VO, a pragmatic proxy measure of  puberty onset. Like our patients, 
these mice had no reduction in reproductive capacity postpubertally, as evidenced by comparable gonadal 
size, morphology, and fertility to WT animals, and were otherwise healthy and of  normal body weight.
In contrast, Lgr4–/– mice had complete failure to enter puberty with a marked reduction in GnRH 
neuronal number at all stages; in keeping with this, Lgr4–/– mice had markedly underdeveloped gonadal 
structures, similar to other rodent models of  GnRH deficiency (28, 29), which in part may be attributed 
to a direct role of  LGR4 in gonadal development (30, 31). KD of  lgr4 in developing zebrafish also led 
to significant defects with GnRH neuronal development and morphology. Mutations in LGR4 have not 
been identified in patients with conditions of  GnRH deficiency such as hypogonadotropic hypogonad-
ism. Notably, there are no individuals homozygous for complete loss-of-function LGR4 mutations found 
in the gnomAD database. This, taken with the early mortality and organ dysfunction seen in the KO 
mouse, suggests that loss-of-function of  LGR4 leading to complete GnRH deficiency would result in a 
very severe phenotype, possibly incompatible with life.
Significantly delayed onset of  puberty is frequently seen in the pediatric clinic because it affects up to 
2% of  the population. Accurate diagnosis has potential health and economic impacts, as late puberty is 
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associated with adverse outcomes, including decreased bone mineral density, osteoporosis (32, 33), psy-
chological distress (34, 35), and poor overall health (6, 36). A clear understanding of  the genetic control of  
pubertal timing will aid diagnosis, which can be difficult and require prolonged, expensive investigation in 
these adolescent patients, and optimize management in this patient group.
In summary, here we have used a combination of  next-generation sequencing methods with RNA 
expression analysis, cell culture, and animal models to identify that defects of  LGR4-Wnt/β-catenin activity 
are associated with compromised development of  the hypothalamic GnRH neuroendocrine network and 
result in delayed onset of  puberty in humans and mice.
Methods
Patients
The large cohort of  individuals (n = 910) with self-limited DP studied here has been described in previ-
ous reports from our group (1, 2, 9). In brief, this cohort includes patients with self-limited DP (n = 492), 
defined as the onset of  Tanner genital stage II (testicular volume > 3 mL) >13.5 years in boys or Tanner 
breast stage II > 13.0 years in girls (i.e., 2 SD later than average pubertal development) (8) and their unaf-
fected relatives. Probands had been managed with specialist pediatric units in Finland between 1982 and 
2004. All affected individuals met the diagnostic criteria for self-limited DP, with chronic illness as a cause 
for functional hypogonadotropic hypogonadism excluded by medical history, clinical examination, and 
biochemical investigations. Congenital or acquired hypogonadotropic hypogonadism, if  suspected, was 
excluded by spontaneous pubertal development by 18 years of  age at follow-up.
Genetic analysis
A total of  67 probands with self-limited DP, selected from those families in the cohort with the greatest 
number of  affected individuals (male, n = 57; female, n = 10), 58 affected family members (male, n = 36; 
female, n = 22), and 35 of  their unaffected family members (male, n = 13; female, n = 22), underwent 
initial genetic analysis. This involved whole-exome sequencing of  DNA extracted from peripheral blood 
leukocytes of  these 160 individuals using a Nimblegen V2 or Agilent V5 platform and Illumina HiSeq 
2000 sequencing. The exome sequences were aligned to the UCSC hg19 reference genome using the Bur-
rows-Wheeler Aligner software (BWA-MEM [bwa-0.7.12]). Picard tools [picard-tools-1.119] was used to 
sort alignments and to mark PCR duplicates. We used the Genome Analysis Toolkit (version 3.4-46) to 
realign around indels and recalibrate quality scores using dbSNP, Mills, and 1000 genomes as reference 
resources. Variant calling and joint genotyping using pedigree information was performed using Haplo-
typeCaller in GVCF mode from the Genome Analysis Toolkit. The resulting variants were filtered using the 
variant quality score recalibration (VQSR) function from GATK.
Variants were analyzed for potential causal variants using filters, including for quality control, predict-
ed function, minor allele frequency (MAF) and biological relevance (Figure 1A). A MAF threshold of  < 
2.5% in the 1000 Genomes database, the NHLBI exome variant server and the ExAC and gnomAD data-
bases was used. A case-control analysis to exclude variants present in more than 1 unaffected control was 
applied. A multiple family filter to retain only genes with variants present in more than 1 proband was also 
performed. Targeted exome sequencing (Fluidigm) of  the remaining candidate genes was then performed 
in 42 further families from the same cohort (288 individuals, 178 with DP; male = 106, female = 72 and 110 
controls; male = 55, female = 55, Figure 1A), with filtering as in (1).
Whole gene rare-variant burden testing was performed after sequencing. Fisher’s exact test was used to 
compare the prevalence of  deleterious variants in our cohort with the Finnish population, using the ExAC 
Browser (Exome Aggregation Consortium [ExAC]: accessed September 2015).
In silico analysis
The amino acid sequence of  the human LGR4 was obtained from UniProt (UniProt id Q9BXB1) (37). The 
LGR4 x-ray structure of  the extracellular domain was retrieved from the Protein Data Bank (38). Homolo-
gy modeling was performed on the intracellular domain by using the in house Phyre2 prediction tool (39). 
FoldX was used to build the 3D structure of  LGR4 mutant proteins and to calculate the difference in free 
energy between the WT and mutant LGR4 (40). The structural analysis was performed manually. The in 
silico predictions were obtained from SIFT and Polyphen2 prediction tools (41, 42).
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Site-directed mutagenesis
LGR4 mutations were inserted in pcDNA3.1/-HA-hLGR4 (provided by Jim Liu and Xing Gong, Insti-
tute of  Molecular Medicine, Houston, Texas, USA) using QuikChange II Site-Directed Mutagenesis Kit 
(Agilent Technologies) following the manufacturer’s instructions. The p.Ile96Val missense mutation was 
inserted using the following primers: forward 5′-CGACCTTTCTTTTGTCCACCCAAAGGCC-3′ and 
reverse 5′-GGCCTTTGGGTGGACAAAAGAAAGGTCGT-3′. The p.Gly363Cys missense mutation was 
inserted using the following primers: forward 5′-TTCCAAGTTTTAATTGTTGCCATGCTCTG-3′ and 
reverse 5′-CAGAGCATGGCAACAATTAAAACTTGGAA-3′. The p.Asp844Gly mutation was inserted 
using the following primers: forward 5′-GGATTTCTACTACGGCTGTGGCATGTACT-3′ and reverse 
5′-AGTACATGCCACAGCGTAGTAGAAATCC-3′. Vectors were fully sequenced after mutagenesis.
Cell culture
HEK293T cell line (sourced from ATCC) was cultured in DMEM (MilliporeSigma) supplemented with 
10% FBS (Invitrogen) and 1% penicillin/streptomycin solution (Pen/Strep; Invitrogen), referred as com-
plete medium. LWnt-3a cell line (gifted by Bethan Thomas and Francesco Dell’Accio, Translational Med-
icine and Therapeutics, QMUL, London, United Kingdom) was cultured in DMEM supplemented with 
10% FBS and 0.4 mg/mL Geneticin (G-418; Thermo Fisher Scientific). Cell growth media were warmed 
before contact with cells. All cells were incubated in a humidified incubator at 37°C and 5% CO2. Cells 
were assessed for mycoplasma contamination (MycoAlert Detection Kit, Lonza) on a monthly basis.
Transfection
Cells were plated at the appropriate density (12.5 × 104 cells/well in a standard 24 well plate, 0.3 × 106 
cells/well in a 6-well cell culture plate or 2.2 × 106 cells/dish in a 10 cm2 dish). After 24 hours, the medi-
um was replaced to a serum-free DMEM for 1 hour. For a 24-well cell culture plate, a total of  0.5 μg/well 
DNA was diluted serum-free in DMEM/High Glucose (0.5 mL/well) and 1 mg/mL polyethylenimine 
(MilliporeSigma). A total of  1 μg/well and 5 μg/dish DNA were used for transfection in 6-well cell culture 
plates and 10 cm2 dishes, respectively. The transfection mixture was gently mixed and incubated at room 
temperature for 10 minutes, before being added dropwise onto the wells. Three hours after transfection, 
the medium was replaced with DMEM complete medium. Luciferase assays were performed in 24-well 
cell culture plates, Rspondin-1 conditioned medium preparation was performed in 10 cm2 dishes and every 
other transfection was performed in 6-well cell culture plates.
Protein extraction and Western blot analysis
Forty-eight hours after transfection, cells were harvested and lysed in RIPA buffer (MilliporeSigma) sup-
plemented with Protease Inhibitor (Roche Diagnostics Ltd.) for 20 minutes on ice, and samples were cen-
trifuged for 20 minutes at 13,000 rpm at 4°C. The concentration of  the supernatant was measured by 
the BCA kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. Equal amount of  
proteins was separated by SDS-PAGE (pre-cast 4%–12% polyacrylamide NuPage BisTris gels; Invitrogen) 
and transferred on nitrocellulose (Promega) membrane. After blocking with 5% nonfat milk in PBS con-
taining 0.1% Tween-20 (PBT) for 1 hour at room temperature, membranes were incubated overnight at 4°C 
with primary antibodies: rabbit anti-HA (Santa Cruz Biotechnology, sc-805, diluted 1:1000) and mouse 
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Santa Cruz Biotechnology, sc-365062, diluted 
1:5000), or mouse anti-β-actin (Abcam, ab8226, diluted 1:5000) in PBT. After washes in PBT, the mem-
branes were probed for 1 hour with IRDye 800 goat anti-rabbit and IRDye 680 goat anti-mouse secondary 
antibody (diluted 1:10,000, Licor). After washes in PBT, membranes were scanned and analyzed using the 
Odyssey Fc Imaging System (Licor).
CHX chase analysis for protein half-life
Forty-eight hours after transfection, cells were treated with or without 50 μg/mL CHX (ab120093, Abcam) 
diluted in complete medium. Proteins were extracted after 0 (no treatment), 3, 6, 9, and 12 hours. Proteins 
were subjected to Western blot with rabbit anti-HA (Santa Cruz Biotechnologies, sc-805, diluted 1:1000) 
and mouse anti-β-actin (Abcam, ab8226, diluted 1:5000) antibodies. Densitometry analysis was performed, 
and the normalized protein levels were converted to percentages, with time = 0 being 100%. HA-LGR4 
half-life was determined using a 1-phase decay equation. The results were plotted as curves for each WT or 
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mutant proteins on which half-life of  each protein was calculated, using the formula: half-life = ln(2)/K. 
The degradation speed, represented by the K value, was compared between each mutant protein, and the 
WT protein using the extra sum-of-squares F test, using GraphPad Prism 7.
Wnt3a and Rspondin-1 conditioned media production
LWnt-3a cells were passaged 1:10 in 10 mL of  DMEM with 10% FBS and 1% pen/strep in T75 and grown 
for 4 days, approximately to confluence. The first batch of  medium was removed and filter sterilized. A 
total of  10 mL of  fresh medium were added, and cells were cultured for a further 3 days. The second batch 
of  medium was collected, filter sterilized, and added to the first batch (1:1). The conditioned medium was 
stored at 4°C or aliquoted and stored at –20°C for long-term storage. Following a transient transfection of  
HEK293T cell line with the vector encoding human Rspondin-1 fused to alkaline phosphatase (AP-hRspo1 
vector, gifted by Andrey Glinka, Division of  Molecular Embryology, Heidelberg, Germany) in 10 cm2 
dishes, conditioned medium, containing secreted AP-hRspo1, was collected at 24 and 48 hours after trans-
fection, centrifuged to remove any cell debris, and filter sterilized using 0.22 μm filters (Sartorious). The 
expression of  the fusion protein was assessed with Western blot (not shown). The conditioned medium was 
stored at 4°C or at –20°C for long-term storage.
TOP-Flash Dual Luciferase Reporter assay
HEK293T cell line was transiently cotransfected with the same amount of TOP-Flash (MilliporeSigma) and 
SV-40 Renilla (Promega) vectors (150 ng each vector/well of a 6-well plate) in conjunction with 200 ng/well 
HA-hLGR4 WT or mutated vectors. The total amount of DNA transfected was kept constant to 500 ng/well 
by adding the appropriate amount of pBlueScript vector. After 24 hours, cells were treated with 500 μL of con-
ditioned medium: control, Wnt3a, Rspo1, or Wnt3a+Rspo1. After a 24-hour treatment, cells were harvested 
and assayed for luciferase using the Dual Luciferase Reporter System (Promega) following the manufacturer’s 
instructions. Each experiment was performed in triplicate and repeated 4 independent times. Samples were pro-
cessed using the POLARstar Omega microplate reader, and data were analyzed using MARS Omega software.
Flow cytometry
HEK293T cells were cotransfected in a 6-well cell culture plate with 800 ng each vector/well of  HA-hLGR4 
(WT or mutated) or pBlueScript (negative controls) and pCDNA3-EGFP (200 ng/well; 13031, Addgene). 
Forty-eight hours after transfection, cells were harvested using Trypsin/EDTA (MilliporeSigma). Cells 
were washed twice with FACS buffer (PBS, 2% FBS, 2 mM EDTA) and incubated for 30 minutes at 4°C 
with the primary antibody (rabbit anti-HA, Santa-Cruz, diluted 1:500 in FACS buffer), or left in FACS 
buffer (negative control). Cells were washed twice in FACS buffer and then incubated with the secondary 
antibody. Negative controls included Alexa Fluor 568 goat anti-rabbit (Thermo Fisher Scientific) dilut-
ed 1:1000 in FACS buffer. Flow cytometry measurements were performed using a BD LSRFortessa flow 
cytometer, and data were analyzed using FlowJo (v7.63, Tree Star, Inc.). Number of  events was kept con-
stant to 10,000/tube. For comparison analysis of  the double-positive populations (+HA/+GFP), the nMFI 
was calculated for the signal emitted by the B530-30 (GFP) and the R670-14 (HA-LGR4) channels, using 
the following formula: nMFI = (MFI sample)/(MFI control).
Animal procedures
Lgr4/Gpr48^Gt mice containing the LacZ knockin allele at the Lgr4 locus were on a CD1 background (12, 
43). Animals had access to both food and water ad libitum and were housed under controlled conditions 
of  light (12 h light, 12 h dark) and temperature (21°C). Female puberty was examined by daily checking 
for the onset of  vaginal opening. Mice were pooled from 7 different litters. Transgenic mice were geno-
typed using genomic DNA isolated from tail tissue samples using the following primer sets: Lgr4 UpA: 
5′-CCAGTCACCACTCTTACACAATGGCTAAC-3′, Lgr4 DownB: 5′-ATTCCCGTAGGAGATAGC-
GTCCTAG-3′, Lgr4 DownC: 5′-GGTCTTTGAGCACCAGAGGAC-3′. The 3 primers are used to amplify 
genomic Lgr4 WT (805 bp) and mutated (650 bp) regions.
Tissue processing
Embryos (E10.5-E14.5-E16.5) or dissected adult brains and gonads from C57BL/6 and Lgr4/Gpr48^Gt 
mice were isolated and fixed in 4% paraformaldehyde (MilliporeSigma) in PBS (pH 7.4) overnight at +4°C 
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and washed 3 times in PBS (pH 7.4). Specimens were cryoprotected in 30% sucrose in PBS and frozen 
in OCT compound (VWR); 20-μm-thick serial coronal sections were collected on Superfrost Plus slides 
(VWR) for GnRH neurons counting. Serial coronal and sagittal sections (12 μm thick) were collected for 
tissue expression analysis.
In situ hybridization and immunohistochemistry
Lgr4 was PCR-amplified from mouse lungs using the following primers: mLgr4 FOR: 5′-TCTTGTTCAT-
CACTGCCTGC-3′, REV: 5′-AGCTGTCCGAGACAAAGGAA-3′. Amplified cDNAs were cloned into 
the vector pGEM-T easy (Promega) and linearized with the appropriate restriction enzymes. Probe prepa-
ration and in situ protocol were performed as previously (44). When colabeling was desired, after in situ, 
the sections were incubated with primary antibodies (anti-GnRH, 20075, Immunostar) diluted 1:1000 in 
PBS–Triton 0.1%, overnight at room temperature (RT) (45). After 3 washes with PBS–Triton 0.1%, the 
slides were incubated for 2 hours at RT with biotin-conjugated goat secondary antibodies (Vector Labora-
tories), diluted 1:300 in PBS and, after further washes, with the avidin–biotin complex (ABC staining kit, 
Vector Laboratories). The sections were reacted with 3,3′-diaminobenzidine (DAB, Vector Laboratories) 
and mounted in an aqueous compound formed by PBS and glycerol (3:1). Images were acquired using a 
Leica DM5500B microscope (Leica), equipped with a DCF295 camera (Leica) and DCViewer software 
(Leica), and then processed with Abode Photoshop CS6 and Adobe Illustrator CS6 software.
Zebrafish experiments
Zebrafish lines and maintenance. The tg(gnrh3:gfp) (46) zebrafish embryos were collected by natural spawn-
ing, and embryos were raised at 28°C under standard conditions (47) and staged according to hours post 
fertilization (hpf) as previously described(48). Beginning from 24 hpf, embryos were cultured in fish water 
containing 0.003% 1-phenyl-2-thiourea (MilliporeSigma) to prevent pigmentation and 0.01% methylene 
blue to prevent fungal growth (47).
Lgr4 KD by MO microinjection. To generate embryos with transient KD of  lgr4, different doses (0.5, 1, 
and 1.25 pmol/embryo) of  a specific splice site-blocking MO, designed to cause the retention of  the intron 
2 during the splicing of  the pre-mRNA, were microinjected. An antisense MO (lgr4MO) against the lgr4 
pre-mRNA were synthesized by GeneTools (Philomath). The lgr4MO (5′-TACTGTGGTTACTTACAG-
GTAGTAG-3′) was designed on the exon2-intron2 boundary. As control for unspecific effects, each exper-
iment was performed in parallel using 1.25 pmol/embryo of  a standard control MO (Std_Ctrl), which has 
no specific target in the zebrafish genome. Morphological evaluation of  lgr4MO-injected embryos at 24 
hpf  showed normal growth with the absence of  gross developmental abnormalities in most of  the injected 
embryos (Supplemental Figure 5A). The mean mortality rate was 12.8% in lgr4 morphants, compared 
with 8.4% of  control embryos, suggesting a low toxicity of  the MO injection. By both RT-PCR and qPCR, 
we observed that lgr4 was reduced in a dose-dependent manner in embryos injected with 0.5, 1, and 1.25 
pmol/embryo lgr4MO, compared with the Std_Ctrls (Supplemental Figure 5, B and C).
Lgr4 KO using the CRISPR/Cas9 System. Two different sgRNA targets were chosen in early exons 
(Exon1-sgRNA CAAACCGCGACGAAACACGACGG and Exon2-sgRNA GGACTGACCAGCGTC-
CCCACCGG) to potentially introduce a large deletion that include the ATG starting site and some reg-
ulatory regions necessary for mRNA transcription. The sgRNA were generated by in vitro transcription 
from oligonucleotide-based templates using the MEGAscript T7 Transcription kit (Ambion), as previously 
described (49).
Injection experiments with different sgRNAs showed that the microinjection of  300 pg Cas9 protein 
together with 200 pg for each sgRNA resulted in a tolerable toxicity with a mean mortality rate of  9.4%, 
compared with 5.3% of  the uninjected embryos used as a control group. Moreover, the great majority of  
Crispants displayed normal morphological development at 24 hpf  (Supplemental Figure 5D).
Both RT-PCR and qPCR experiments performed in single embryos revealed a high efficiency of  gene 
inactivation. A total of  39% and 43% of Crispants showed monoallelic and biallelic inactivation of  the lgr4 
gene, respectively. Lgr4 expression analyses clearly demonstrated that the heterozygous and homozygous 
deletion of  the lgr4 gene resulted in a concomitant reduction of  lgr4 mRNA (Supplemental Figure 5, E and D).
Live-cell imaging of  GnRH3 fibers in lgr4 KD and KO embryos. To assess the role of  lgr4 during GnRH3 
fibers development, lgr4 KD (morphants) and lgr4 KO (Crispants) embryos were anesthetized with tricaine, 
embedded at 48 or 72 hpf  in UltraPure Low Melting Point Agarose (Thermo Fisher Scientific), and ana-
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lyzed using a confocal laser scanning microscope (Nikon C2+) with a ×20 objective. GnRH3 fiber structure 
was assessed using ImageJ software (NIH). Owing to the complexity of  GnRH3 fibers, a specific region of  
interest (ROI) was selected and analyzed at each developmental stage, with background fluorescence sub-
tracted from each image. The number of  green pixels within each ROI was used as a proxy for the amount 
of  GnRH3 fibers. Given the previous characterization of  KD and KO strategies, after confocal acquisition 
at 48 and 72 hpf, the total RNA was extracted from single embryos (Std_Ctrls and morphants, and uninject-
ed ctrls and Crispants) and the expression of  lgr4 was confirmed by qPCR as previously described.
Statistics
For all experiments, data are shown as mean ± SEM. To determine statistical significance for parametric 
tests, the unpaired 2-tailed t test or, for multiple comparisons, 1-way ANOVA was used. Nonparametric 
tests were used when the data did not follow a specific distribution. In this case, for multiple comparison, 
the Kruskal-Wallis test was used. P values less than 0.05 and 0.01 were considered statistically significant. 
A P value less than 0.001 was considered highly significant. The statistical analysis was performed using 
GraphPad Prism7 (GraphPad Software).
Study approval
Patients. Written informed consent was obtained from all participants. The study protocol was approved by 
the Ethics Committee for Pediatrics, Adolescent Medicine and Psychiatry, Hospital District of  Helsinki and 
Uusimaa (570/E7/2003). UK ethical approval was granted by the London-Chelsea NRES committee (13/
LO/0257). The study was conducted in accordance with the guidelines of  The Declaration of  Helsinki.
Animal studies. The study was carried out in accordance with the recommendation of  the Local Ethical 
Committee of  Université Libre de Bruxelles, and experimental procedures were approved under the Ethical 
Protocol 534N. All zebrafish husbandry and all experiments were performed under standard conditions in 
accordance with institutional (University of  Milan) and Italian national ethical and animal welfare guide-
lines and regulations.
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